Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002055040-26-000001
Filing Date
2026-01-06
Accepted
2026-01-06 14:17:11
Documents
1
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3700
  Complete submission text file 0002055040-26-000001.txt   5261
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Issuer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1219 HULL TERRACE, 1B EVANSTON IL 60202
Business Address
Betts Wendy J (Reporting) CIK: 0002055040 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41097 | Film No.: 26510633